Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY900014 formulations PK/PD study
NCT02636361Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2015
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro in diabetes mellitus (DM) (5 arms), sponsored by Eli Lilly and Company. Primary endpoint: Area Under The Concentration Curve (AUC 0-30mins) of Insulin Lispro. Started Dec 2015; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02636361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636361.